Asit Parikh, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 1,000 shares at $7.55 ($8K) on 2023-04-10, disclosed to the SEC on 2023-04-11.
Open-market purchase of $8k PHAT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| PHAT | BUY | 2024-12-16 | $162K | — | Filing → |
| PHAT | BUY | 2023-11-08 | $59K | — | Filing → |
| PHAT | BUY | 2023-02-14 | $39K | — | Filing → |